edgepedia

Medical and health researchers

8,517 articles

Philip J. Cowen

Philip J. Cowen is a psychiatrist and Professor of Psychopharmacology at the University of Oxford whose 1997 Lancet tryptophan-depletion study showed how serotonin relates to depressive relapse.

Philip J. Fialkow

Philip J. Fialkow (1934–1996) was an American physician-scientist and hematologist at the University of Washington who first showed that leukemia is a clonal stem-cell disease, and later served as the medical school's dean.

Philip J. Landrigan

Philip J. Landrigan is an American pediatrician and epidemiologist whose El Paso lead studies helped remove lead from gasoline and shaped children's environmental health policy.

Philip Jones (cancer researcher)

Philip H. Jones is a British clinician-scientist who studies the earliest stages of cancer, and a Cambridge professor and Sanger Institute group leader elected a Fellow of the Royal Society in 2023.

Philip L. Felgner

Philip L. Felgner is an American biochemist who pioneered lipofection, delivering DNA and RNA into cells with synthetic cationic lipids, and won the 2022 Robert Koch Prize.

Philip Levine (physician)

Philip Levine (1900–1987) was a Russian-born American physician, bacteriologist, and serologist who established the Rh factor as the cause of hemolytic disease of the newborn.

Philip McGuire

Philip McGuire is a British psychiatrist and Professor of Psychiatry at the University of Oxford, known for brain imaging and clinical trial research on schizophrenia and psychosis.

Philip McMaster

Philip Duryee McMaster (1891–1973) was an American pathologist and microbiologist at the Rockefeller Institute in New York whose work on blood clotting and gallbladder function entered clinical diagnostic practice.

Philip Mease

Philip J. Mease is an American rheumatologist, clinical professor at the University of Washington and director of rheumatology research at Swedish Medical Center in Seattle.

Philip N. Hawkins

Philip N. Hawkins, also known as Philip Hawkins, is a British rheumatologist at University College London who developed SAP scintigraphy for imaging amyloid deposits and founded the NHS National Amyloidosis Centre in 1999.

Philip N. Newsome

Philip N. Newsome is a British hepatologist known for leading trials of semaglutide and liraglutide in fatty liver disease and co-leading the renaming of NAFLD as MASLD.

Philip Needleman

Philip Needleman (1939–2024) was an American pharmacologist who chaired pharmacology at Washington University, discovered COX-2, and led Monsanto and Pharmacia research that produced the arthritis drug Celebrex.

Philip Quirke

Philip Quirke is a British pathologist at the University of Leeds whose work on rectal cancer surgery margins changed practice and improved bowel cancer survival.

Philip R. Dodge

Philip R. Dodge (1923–2009) was an American pediatric neurologist, remembered as a founder of pediatric neurology, who established Mass General's pediatric neurology department in 1956.

Philip R. Krause

Philip R. Krause is an American physician-scientist in vaccinology and virology who served at the FDA from 1991 to 2021, helping supervise COVID-19 vaccine review.

Philip R. Schauer

Philip R. Schauer is an American bariatric and metabolic surgeon known for leading the STAMPEDE trial comparing surgery with drug therapy for type 2 diabetes.

Philip Raskin

Philip Raskin (1940–2026) was an American endocrinologist and diabetes researcher who spent 53 years at UT Southwestern Medical Center in Dallas, leading NIH trials including DCCT/EDIC, GRADE, and D2d.

Philip Rubin

Philip Rubin (1927–2014) was an American radiation oncologist who built the University of Rochester's radiation oncology department and became an international authority on late radiation effects on normal tissue.

Philip S. Hench

Philip S. Hench was an American rheumatologist at the Mayo Clinic who led the 1948 cortisone trials for rheumatoid arthritis, winning the 1950 Nobel Prize in Medicine.

Philip S. Schein

Philip S. Schein is a medical oncologist and pharmacologist who held senior posts at the National Cancer Institute and Georgetown, founded U.S. Bioscience, and served as president of ASCO.

Philip Scheltens

Philip Scheltens is a Dutch neurologist and Alzheimer's researcher, emeritus professor at Amsterdam UMC, founder of its Alzheimer Center, and now head of the Dementia Fund at EQT Life Sciences.

Philip Seeman

Philip Seeman (1934–2021) was a Canadian neuropharmacologist at the University of Toronto who identified the dopamine D2 receptor as the brain target of antipsychotic drugs, founding the dopamine hypothesis of schizophrenia.

Philip W. Hinds

Philip W. Hinds is an American cancer biologist at Tufts University School of Medicine in Boston who studies how pRB and D-type cyclins control the cell cycle.

Philip W. Kantoff

Philip W. Kantoff is an American medical oncologist who led genitourinary oncology at Dana-Farber for 28 years, then chaired medicine at Memorial Sloan Kettering from 2015.

Philip W. Lavori

Philip W. Lavori, also published as Philip Lavori, is a biostatistician and emeritus professor of Biomedical Data Science at Stanford University, known for adaptive treatment strategies.

Philip W. Shaul

Philip W. Shaul is an American physician-scientist in vascular biology who directs the Center for Pulmonary and Vascular Biology at UT Southwestern Medical Center in Dallas.

Philipp E. Scherer

Philipp E. Scherer is a Swiss-born cell biologist who discovered the fat-cell hormone adiponectin in 1995 and directs the Touchstone Diabetes Center at UT Southwestern in Dallas.

Philipp Harter

Philipp Harter is a German gynecologic oncologist, director of gynecology and gynecologic oncology at Evang. Kliniken Essen-Mitte in Essen and speaker of the AGO study group.

Philipp Schwartz

Philipp Schwartz (1894–1977) was a neuropathologist dismissed under Nazi law in 1933 who founded the Notgemeinschaft deutscher Wissenschaftler im Ausland, placing over 2,600 dismissed scholars worldwide.

Philippe Armand

Philippe Armand is a French-American? No—Philippe Armand is a physician-scientist and Chief of the Division of Lymphoma at Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School.